Kimberly-Clark Corporation (KMB) posted better-than-expected results on Tuesday, proving that sometimes the basics—solid execution and disciplined cost management—still work wonders. The company behind household staples like Kleenex, Huggies, and Cottonelle is gaining momentum, even as it navigates a strategic retreat from lower-margin business lines.
The quarter showed the company making real progress across its global footprint, with management particularly excited about international margin opportunities. And they're putting their money where their mouth is, literally, with a dividend increase that signals confidence in the transformation underway.
Breaking Down the Quarter
Kimberly-Clark delivered adjusted earnings of $1.86 per share for the fourth quarter, comfortably ahead of the $1.81 analyst consensus. That's the kind of beat that gets investors' attention, especially in the consumer staples sector where predictability matters.
Sales came in at $4.08 billion, just shy of the $4.09 billion Street estimate. Total revenues declined 0.6% year-over-year, but here's where context matters: organic sales actually grew 2.1%. The headline revenue pressure stems largely from portfolio changes, particularly the company's deliberate exit from the U.S. private-label diaper business—a strategic move to focus on higher-margin branded products.
The margin story looks solid. Gross margin hit 35.9%, while adjusted gross margin reached 37%, matching the prior year. But management made clear on the earnings call that international gross margin represents a "big opportunity" going forward, suggesting there's more upside ahead as efficiency initiatives take hold overseas.
Adjusted operating profit climbed to $629 million, up 13.1% from the year-ago period. That growth came from strong productivity gains and lower planned spending on marketing, research, and general expenses. Net interest expense held steady at $54 million, broadly in line with last year.
Company executives emphasized they're seeing strong progress across multiple international markets, specifically calling out Australia, Brazil, and South Korea as bright spots in the portfolio.
Chairman and CEO Mike Hsu connected the dots to the bigger picture: "Acquiring Kenvue is a powerful next step in our transformation that will compound the momentum we're already delivering across Kimberly-Clark. Importantly, it will also enable us to raise the standard of care for billions of people around the world."
The balance sheet shows cash and equivalents of $688 million, with inventories at $1.475 billion at quarter-end.
Shareholder Returns Get a Bump
Kimberly-Clark announced a dividend increase to $1.28 per share quarterly, up from $1.26 previously. The dividend is payable on April 2, 2026. It's a modest bump, but dividend increases matter in the consumer staples world, where income-focused investors dominate the shareholder base.
Looking Ahead to 2026
Management's 2026 outlook reflects both caution and confidence. The company expects reported net sales to take a roughly 50-basis-point hit from exiting the U.S. private-label diaper business, with currency translation expected to be largely neutral.
On the profit side, things get more interesting. Kimberly-Clark is forecasting mid- to high-single-digit adjusted operating profit growth on a constant-currency basis.
The real headline: double-digit adjusted earnings per share growth from continuing operations on a constant-currency basis. That growth is expected to come from multiple sources—a projected jump in equity-company income, flat net interest expense, an adjusted effective tax rate around 23%, and essentially unchanged share count versus 2025.
Add in a favorable currency translation impact of approximately 130 basis points, and you've got a setup that should deliver meaningful bottom-line growth.
Shares of Kimberly-Clark were down 0.11% at $101.03 at the time of publication on Tuesday.
